Potential of circulating tumor DNA to refine immunotherapy

Cancer. 2023 Jun 1;129(11):1646-1648. doi: 10.1002/cncr.34714. Epub 2023 Mar 4.

Authors

Rebecca J Lee^{1

2

3}, Jason J Luke^{4

5}

Affiliations

¹ University of Manchester, Manchester, UK.
² The Francis Crick Institute, London, UK.
³ The Christie NHS Foundation Trust, Manchester, UK.
⁴ UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
⁵ Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor / genetics
Circulating Tumor DNA* / genetics
Humans
Immunotherapy
Neoplasms* / genetics
Neoplasms* / pathology
Neoplasms* / therapy

Substances

Circulating Tumor DNA
Biomarkers, Tumor

Grants and funding